Article
In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice
31 May 2014
Abstract excerpt
Although in utero hematopoietic cell transplantation is a promising strategy to treat congenital hematopoietic disorders, levels of engraftment have not been therapeutic for diseases in which donor cells have no survival advantage. We used an antibody against the murine c-Kit receptor (ACK2) to deplete fetal host hematopoietic stem cells (HSCs) and increase space within the hematopoietic niche for donor cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
